BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 11207517)

  • 1. Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate.
    Fakheri H; Malekzadeh R; Merat S; Khatibian M; Fazel A; Alizadeh BZ; Massarrat S
    Aliment Pharmacol Ther; 2001 Mar; 15(3):411-6. PubMed ID: 11207517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection.
    Liu WZ; Xiao SD; Shi Y; Wu SM; Zhang DZ; Xu WW; Tytgat GN
    Aliment Pharmacol Ther; 1999 Mar; 13(3):317-22. PubMed ID: 10102964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week.
    Xiao SD; Liu WZ; Hu PJ; Xia DH; Tytgat GN
    Aliment Pharmacol Ther; 1999 Mar; 13(3):311-5. PubMed ID: 10102963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial.
    Laine L; Hunt R; El-Zimaity H; Nguyen B; Osato M; Spénard J
    Am J Gastroenterol; 2003 Mar; 98(3):562-7. PubMed ID: 12650788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradication.
    Choi IJ; Jung HC; Choi KW; Kim JH; Ahn DS; Yang US; Rew JS; Lee SI; Rhee JC; Chung IS; Chung JM; Hong WS
    Aliment Pharmacol Ther; 2002 Jan; 16(1):145-51. PubMed ID: 11856089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial.
    Mirbagheri SA; Hasibi M; Abouzari M; Rashidi A
    World J Gastroenterol; 2006 Aug; 12(30):4888-91. PubMed ID: 16937475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.
    Bazzoli F; Zagari RM; Pozzato P; Fossi S; Ricciardiello L; Nicolini G; De Luca L; Berretti D; Alampi G; Di Pietro C; Morelli P; Roda E
    Aliment Pharmacol Ther; 2002 Jan; 16(1):153-8. PubMed ID: 11856090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Furazolidone-based triple 'rescue therapy' vs. quadruple 'rescue therapy' for the eradication of Helicobacter pylori resistant to metronidazole.
    Isakov V; Domareva I; Koudryavtseva L; Maev I; Ganskaya Z
    Aliment Pharmacol Ther; 2002 Jul; 16(7):1277-82. PubMed ID: 12144577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-line Helicobacter pylori eradication with a furazolidone-based regimen in patients who have failed a metronidazole-based regimen.
    Sotoudehmanesh R; Malekzadeh R; Vahedi H; Dariani NE; Asgari AA; Massarrat S
    Digestion; 2001; 64(4):222-5. PubMed ID: 11842278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Furazolidone-based, metronidazole-based, or a combination regimen for eradication of Helicobacter pylori in peptic ulcer disease.
    Khatibian M; Ajvadi Y; Nasseri-Moghaddam S; Ebrahimi-Dariani N; Vahedi H; Zendehdel N; Sotoudehmanesh R; Agah S; Mikaeli J; Pourshams A; Ali-Asgari A; Malekzadeh R; Massarrat S
    Arch Iran Med; 2007 Apr; 10(2):161-7. PubMed ID: 17367217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies.
    Wong WM; Wong BC; Lu H; Gu Q; Yin Y; Wang WH; Fung FM; Lai KC; Xia HH; Xiao SD; Lam SK
    Aliment Pharmacol Ther; 2002 Apr; 16(4):793-8. PubMed ID: 11929398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicentre, randomized, double-blind study.
    Lu H; Zhang DZ; Hu PJ; Li ZS; Lu XH; Fang XC; Xiao SD
    Aliment Pharmacol Ther; 2001 Dec; 15(12):1975-9. PubMed ID: 11736729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
    Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
    Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
    Kalach N; Benhamou PH; Bergeret M; Gottrand F; Husson MO; Barbier C; Dupont C; Raymond J
    Arch Pediatr; 2002 Feb; 9(2):130-5. PubMed ID: 11915493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of different doses of furazolidone with amoxicillin and omeprazole on eradication of Helicobacter pylori.
    Roghani HS; Massarrat S; Shirekhoda M; Butorab Z
    J Gastroenterol Hepatol; 2003 Jul; 18(7):778-82. PubMed ID: 12795748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance.
    Wong BC; Wong WM; Wang WH; Fung FM; Lai KC; Chu KM; Yuen ST; Leung SY; Hu WH; Yuen MF; Lau GK; Chan CK; Lam SK
    Aliment Pharmacol Ther; 2001 Mar; 15(3):403-9. PubMed ID: 11207516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.
    Miehlke S; Kirsch C; Schneider-Brachert W; Haferland C; Neumeyer M; Bästlein E; Papke J; Jacobs E; Vieth M; Stolte M; Lehn N; Bayerdörffer E
    Helicobacter; 2003 Aug; 8(4):310-9. PubMed ID: 12950604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison between sequential therapy and a modified bismuth-based quadruple therapy for Helicobacter pylori eradication in Iran: a randomized clinical trial.
    Fakheri H; Taghvaei T; Hosseini V; Bari Z
    Helicobacter; 2012 Feb; 17(1):43-8. PubMed ID: 22221615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group.
    Wurzer H; Rodrigo L; Stamler D; Archambault A; Rokkas T; Skandalis N; Fedorak R; Bazzoli F; Hentschel E; Mora P; Archimandritis A; Megraud F
    Aliment Pharmacol Ther; 1997 Oct; 11(5):943-52. PubMed ID: 9354205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of furazolidone-based quadruple therapy for eradication of Helicobacter pylori infection in Iranian patients resistant to metronidazole-based quadruple therapy.
    Ebrahimi-Dariani N; Mirmomen S; Mansour-Ghanaei F; Noormohammadpoor P; Sotodehmanesh R; Haghpanah B; Bahrami H
    Med Sci Monit; 2003 Aug; 9(8):PI105-8. PubMed ID: 12942042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.